Literature DB >> 21883383

Introduction: Adipokines and cardiovascular disease.

Chao-Yu Miao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21883383     DOI： 10.1111/j.1440-1681.2011.05598.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN： 0305-1870            Impact factor:   2.557


× No keyword cloud information.
  6 in total

1.  Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression.

Authors:  Zhi-Yong Li; Si-Li Zheng; Pei Wang; Tian-Ying Xu; Yun-Feng Guan; Yi-Jie Zhang; Chao-Yu Miao
Journal:  CNS Neurosci Ther       Date:  2014-01-07       Impact factor: 5.243

2.  Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase.

Authors:  Tian-Ying Xu; Sai-Long Zhang; Guo-Qiang Dong; Xin-Zhu Liu; Xia Wang; Xiao-Qun Lv; Qi-Jun Qian; Ruo-Yu Zhang; Chun-Quan Sheng; Chao-Yu Miao
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

3.  Subfatin concentration decreases in acute coronary syndrome.

Authors:  Mustafa Yilmaz; Mehmet Cagri Goktekin; Nevin Ilhan
Journal:  Biochem Med (Zagreb)       Date:  2022-04-15       Impact factor: 2.313

4.  Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT.

Authors:  Xia Wang; Tian-Ying Xu; Xin-Zhu Liu; Sai-Long Zhang; Pei Wang; Zhi-Yong Li; Yun-Feng Guan; Shu-Na Wang; Guo-Qiang Dong; Shu Zhuo; Ying-Ying Le; Chun-Quan Sheng; Chao-Yu Miao
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

Review 5.  Metrnl: a secreted protein with new emerging functions.

Authors:  Si-Li Zheng; Zhi-Yong Li; Jie Song; Jian-Min Liu; Chao-Yu Miao
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

6.  The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2.

Authors:  Jung Ok Lee; Won Seok Byun; Min Ju Kang; Jeong Ah Han; Jiyoung Moon; Min-Jeong Shin; Ho Jun Lee; Ji Hyung Chung; Jin-Seok Lee; Chang-Gue Son; Kwon-Ho Song; Tae Woo Kim; Eun-Soo Lee; Hong Min Kim; Choon Hee Chung; Kevin R W Ngoei; Naomi X Y Ling; Jonathan S Oakhill; Sandra Galic; Lisa Murray-Segal; Bruce E Kemp; Kyoung Min Kim; Soo Lim; Hyeon Soo Kim
Journal:  FEBS J       Date:  2020-04-19       Impact factor: 5.542
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.